Latest news with #TrendsandForecast
Yahoo
28-05-2025
- Business
- Yahoo
Spain Hotel Market Forecast Report and Company Analysis 2025-2033 Marriott, Melia Hotels, Barcelo, NH, TUI, Accor, Wyndham, and InterContinental
Spanish Hotel Market Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Spain Hotel Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to offering. The Spain Hotel Market is projected to grow from US$ 25.90 billion in 2024 to US$ 34.54 billion by 2033, advancing at a CAGR of 3.25% from 2025 to 2033. This growth is fueled by an array of factors including Spain's diverse cultural and historical allure, surging domestic travel, favorable climate, infrastructure enhancements, governmental support, and the multi-faceted appeal of coastal, urban, and rural attractions. Spain's captivating landscapes, rich history, and vibrant culture make it an enduringly popular destination. The country's hotel sector has adeptly adapted to modern travelers' tastes, blending contemporary luxury with classic charm to position Spain as a leader in hospitality. Historical landmarks, exceptional beaches, and efficient transportation contribute to its draw, with cities like Madrid and Barcelona complementing serene seaside and rural retreats. Rising disposable incomes and environmentally-conscious government programs further boost the market. The industry's recovery post-pandemic and the growing inclination towards wellness and sustainable tourism enhance Spain's standing as a top destination. Growth Drivers for the Spain Hotel Market Infrastructure Development: Enhanced infrastructure plays an instrumental role in market growth by improving accessibility and encouraging travel. Expansions in high-speed trains, airports, and roadways facilitate easier access for international and local tourists, boosting occupancy in regions such as Costa Brava and the Canary Islands. The strategic partnership between Hotelbeds and Barcelo in November 2023 aims to amplify the market presence of 130 Barcelo hotels, enriching Spain's image as a premier travel hub. Growing Travel Industry: Spain's tourism sector continues to flourish, driven by its extensive cultural offerings and varied landscapes, from idyllic coastal spots to buzzing metropolises. The industry significantly impacts the economy, reflecting favorably on GDP growth. A blend of strong domestic travel and constant foreign influx sustains the demand for diverse hospitality services, contributing to the sector's robust performance. Increasing Government Assistance and Investment in Infrastructure: Proactive governmental policies and investments in tourism infrastructure significantly bolster Spain's global competitiveness as a travel destination. Infrastructure upgrades, marketing ventures, and international agreements solidify its lead in hospitality-driven growth. Notably, the proposed investment of Euro 2.4 billion in Madrid's Adolfo Suarez-Madrid Barajas Airport aims to elevate its prominence as Europe's gateway to Latin America. Challenges in the Spain Hotel Market Seasonality: The cyclical nature of tourism demand, peaking in summer, poses a challenge in terms of revenue stability and occupancy rates. To maintain profitability year-round, establishments must navigate seasonal labor needs and promotional activities. Sustainability Pressures: The industry's push towards eco-friendly practices introduces challenges, notably for smaller setups grappling with the cost of adopting sustainable technologies. The financial burden and operational alterations associated with meeting environmental standards underscore the need for strategic adaptation within the sector. Spain Hotel Overview by Cities Madrid Hotel Market: A vibrant tourism and business destination, Madrid's hospitality sector thrives with a concentration of luxury, boutique, and budget accommodations tailored to varied clientele. Seasonal peaks in occupancy, driven by festivals and events, highlight its dynamic market. Barcelona Hotel Market: The influx of international and business visitors underpins Barcelona's hotel industry. Diverse accommodations cater to different traveler demands, with spring and summer seeing heightened activity due to the city's cultural allure and events calendar. Key Players:Company Overview, Key Persons, Recent Developments, Sales Analysis Marriott International Inc. Melia Hotels International Barcelo Hotel Group NH Hotel Group TUI Hotels & Resorts Accor Hotels Wyndham Hotels & Resorts InterContinental Hotels Group Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $25.9 Billion Forecasted Market Value (USD) by 2033 $34.54 Billion Compound Annual Growth Rate 3.2% Regions Covered Spain Key Topics Covered: 1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Spain Hotel Market6. Market Share Analysis6.1 By Type6.2 By Business Model6.3 By Sales Channel6.4 By Age Group6.5 By Gender6.6 By Star Rating6.7 By Cities7. Type7.1 Economy7.2 Midscale7.3 Upscale & Upper-Upscale7.4 Luxury8. Business Model8.1 Chain8.2 Independent9. Sales Channel9.1 Offline9.2 Online10. Age Group10.1 18-24 years10.2 25-34 years10.3 35-44 years10.4 45-54 years10.5 55-64 years11. Gender11.1 Male11.2 Female12. Star Rating12.1 1 Star12.2 2 Star12.3 3 Star12.4 4 Star12.5 5 Star13. Cities13.1 Madrid13.2 Barcelona13.3 Palma13.4 Seville13.5 Valencia13.6 Granada13.7 Malaga13.8 Bilbao13.9 Alicante13.10 Cordoba13.11 San Sebastian13.12 Santiago de Compostela13.13 Santander13.14 Cadiz14. Porter's Five Forces Analysis14.1 Bargaining Power of Buyers14.2 Bargaining Power of Suppliers14.3 Degree of Rivalry14.4 Threat of New Entrants14.5 Threat of Substitutes15. SWOT Analysis15.1 Strength15.2 Weakness15.3 Opportunity15.4 Threat16. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Spanish Hotel Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
28-05-2025
- Business
- Yahoo
Spain Hotel Market Forecast Report and Company Analysis 2025-2033 Marriott, Melia Hotels, Barcelo, NH, TUI, Accor, Wyndham, and InterContinental
Spanish Hotel Market Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Spain Hotel Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to offering. The Spain Hotel Market is projected to grow from US$ 25.90 billion in 2024 to US$ 34.54 billion by 2033, advancing at a CAGR of 3.25% from 2025 to 2033. This growth is fueled by an array of factors including Spain's diverse cultural and historical allure, surging domestic travel, favorable climate, infrastructure enhancements, governmental support, and the multi-faceted appeal of coastal, urban, and rural attractions. Spain's captivating landscapes, rich history, and vibrant culture make it an enduringly popular destination. The country's hotel sector has adeptly adapted to modern travelers' tastes, blending contemporary luxury with classic charm to position Spain as a leader in hospitality. Historical landmarks, exceptional beaches, and efficient transportation contribute to its draw, with cities like Madrid and Barcelona complementing serene seaside and rural retreats. Rising disposable incomes and environmentally-conscious government programs further boost the market. The industry's recovery post-pandemic and the growing inclination towards wellness and sustainable tourism enhance Spain's standing as a top destination. Growth Drivers for the Spain Hotel Market Infrastructure Development: Enhanced infrastructure plays an instrumental role in market growth by improving accessibility and encouraging travel. Expansions in high-speed trains, airports, and roadways facilitate easier access for international and local tourists, boosting occupancy in regions such as Costa Brava and the Canary Islands. The strategic partnership between Hotelbeds and Barcelo in November 2023 aims to amplify the market presence of 130 Barcelo hotels, enriching Spain's image as a premier travel hub. Growing Travel Industry: Spain's tourism sector continues to flourish, driven by its extensive cultural offerings and varied landscapes, from idyllic coastal spots to buzzing metropolises. The industry significantly impacts the economy, reflecting favorably on GDP growth. A blend of strong domestic travel and constant foreign influx sustains the demand for diverse hospitality services, contributing to the sector's robust performance. Increasing Government Assistance and Investment in Infrastructure: Proactive governmental policies and investments in tourism infrastructure significantly bolster Spain's global competitiveness as a travel destination. Infrastructure upgrades, marketing ventures, and international agreements solidify its lead in hospitality-driven growth. Notably, the proposed investment of Euro 2.4 billion in Madrid's Adolfo Suarez-Madrid Barajas Airport aims to elevate its prominence as Europe's gateway to Latin America. Challenges in the Spain Hotel Market Seasonality: The cyclical nature of tourism demand, peaking in summer, poses a challenge in terms of revenue stability and occupancy rates. To maintain profitability year-round, establishments must navigate seasonal labor needs and promotional activities. Sustainability Pressures: The industry's push towards eco-friendly practices introduces challenges, notably for smaller setups grappling with the cost of adopting sustainable technologies. The financial burden and operational alterations associated with meeting environmental standards underscore the need for strategic adaptation within the sector. Spain Hotel Overview by Cities Madrid Hotel Market: A vibrant tourism and business destination, Madrid's hospitality sector thrives with a concentration of luxury, boutique, and budget accommodations tailored to varied clientele. Seasonal peaks in occupancy, driven by festivals and events, highlight its dynamic market. Barcelona Hotel Market: The influx of international and business visitors underpins Barcelona's hotel industry. Diverse accommodations cater to different traveler demands, with spring and summer seeing heightened activity due to the city's cultural allure and events calendar. Key Players:Company Overview, Key Persons, Recent Developments, Sales Analysis Marriott International Inc. Melia Hotels International Barcelo Hotel Group NH Hotel Group TUI Hotels & Resorts Accor Hotels Wyndham Hotels & Resorts InterContinental Hotels Group Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $25.9 Billion Forecasted Market Value (USD) by 2033 $34.54 Billion Compound Annual Growth Rate 3.2% Regions Covered Spain Key Topics Covered: 1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Spain Hotel Market6. Market Share Analysis6.1 By Type6.2 By Business Model6.3 By Sales Channel6.4 By Age Group6.5 By Gender6.6 By Star Rating6.7 By Cities7. Type7.1 Economy7.2 Midscale7.3 Upscale & Upper-Upscale7.4 Luxury8. Business Model8.1 Chain8.2 Independent9. Sales Channel9.1 Offline9.2 Online10. Age Group10.1 18-24 years10.2 25-34 years10.3 35-44 years10.4 45-54 years10.5 55-64 years11. Gender11.1 Male11.2 Female12. Star Rating12.1 1 Star12.2 2 Star12.3 3 Star12.4 4 Star12.5 5 Star13. Cities13.1 Madrid13.2 Barcelona13.3 Palma13.4 Seville13.5 Valencia13.6 Granada13.7 Malaga13.8 Bilbao13.9 Alicante13.10 Cordoba13.11 San Sebastian13.12 Santiago de Compostela13.13 Santander13.14 Cadiz14. Porter's Five Forces Analysis14.1 Bargaining Power of Buyers14.2 Bargaining Power of Suppliers14.3 Degree of Rivalry14.4 Threat of New Entrants14.5 Threat of Substitutes15. SWOT Analysis15.1 Strength15.2 Weakness15.3 Opportunity15.4 Threat16. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Spanish Hotel Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27-05-2025
- Business
- Yahoo
United States Online Food Delivery Market Forecast Report and Company Analysis 2025-2033 Featuring Grubhub, Doordash, Uber, Postmates, Dominos, Kroger, Blue Apron, and HelloFresh
Driven by smartphone adoption, convenience, and evolving consumer lifestyles, this growth will be supported by platforms like Uber Eats, DoorDash, and Grubhub. Technological advancements, strategic alliances, and aggressive marketing are key factors fueling expansion, despite challenges like fierce competition. Major cities, including New York and Los Angeles, showcase the sector's vibrant dynamics. U.S. Online Food Delivery Market Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "United States Online Food Delivery Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to States Online Food Delivery Market is expected to reach US$ 72.94 billion by 2033 from US$ 31.11 billion in 2024, with a CAGR of 9.93% from 2025 to 2033. The demand for delivery services is fueled by a number of factors, including the growing popularity of smartphones, convenience, a wide variety of food selections, technological advancements, and the development of busy lifestyles. With services like Uber Eats, DoorDash, Grubhub, and Postmates providing easy access to a large selection of eateries, online food delivery has become increasingly popular in the US. Consumers can purchase meals online or through mobile apps, with the option of pickup or delivery. These services frequently offer promotions or subscription plans, and they usually charge for delivery. Particularly during the COVID-19 pandemic, the rise of online ordering has changed eating habits and made meal delivery a commonplace aspect of American the rise of busy lifestyles, and increased smartphone usage are the main drivers of the U.S. online food delivery market's expansion. Food ordering is now simple due to the growth of websites like Grubhub, DoorDash, and Uber Eats. More customers are drawn to restaurants with a variety of menu alternatives, including healthier and specialty cuisine options. Usage is further increased via subscription models, loyalty benefits, and simple payment methods. Technological developments that continue to improve consumer experience, such real-time tracking and AI for tailored recommendations, are driving market April 2024: Amazon's new Prime monthly grocery delivery subscription service, available to Prime members and anyone with a registered electronic benefit transfer card, was welcomed in more than 3,500 American cities and towns. This subscription, which costs $9.99 per month for Prime members and pays for itself after one delivery order in a month, gives Prime members access to more convenient delivery and pickup options as well as unlimited grocery delivery on orders of $35 or more from Whole Foods, Amazon Fresh, and a variety of local grocery and specialty stores that are all available on Drivers for the Online Food Delivery Market Strategic Alliances and InvestmentsThe growing emphasis on strategic alliances and acquisitions is a major factor driving the expansion of the US online food delivery sector. Leading businesses are partnering with grocery shops, restaurant chains, and other food service providers in an effort to expand their market share and enhance their service offerings. Through these partnerships, meal delivery apps can offer a wider variety of food options, catering to a wider customer base. Grubhub and Homewood Suites by Hilton teamed together in June 2023 to provide food options for visitors at about 500 locations throughout the US. Tourists may simply place orders from nearby restaurants using the Grubhub app's geolocation and rapid response (QR) codes, adding to their dining options and improving their overall prominent organizations can enhance their efficiency, fortify their position, and seamlessly integrate new technologies by purchasing smaller delivery and technology firms. In addition, partnerships with large supermarket chains lead to the launch of grocery delivery services, which benefit consumers and create new revenue streams. These strategic choices boost key players' competitive edge and encourage creativity and efficiency, which expands the market as a for Marketing and PromotionThe industry for online food delivery is mostly driven by aggressive marketing and promotional initiatives. In order to raise brand awareness and draw in new customers, businesses are making significant investments in advertising across a range of platforms, including social media, television (TV), and online channels, according to the outlook for the US online meal delivery market. Discounts, free shipping, and loyalty plans are examples of promotional offerings that are essential for keeping current customers and promoting regular use of the service. For instance, Grubhub and Amazon extended its free Grubhub+ deal for another year in June 2023 for American Prime members, providing exceptional savings on restaurant purchases and no delivery costs. This collaboration raised the value of Prime by giving members access to exclusive dining options and fantastic prices through Grubhub's working with well-known events or celebrities at particular seasons of the year boosts brand awareness and human engagement. Particularly effective are these marketing techniques in converting traditional in-person diners to online delivery customers. Delivery platforms can gain a competitive edge, boost user acquisition, and promote ongoing market expansion by employing creative marketing strategies to regularly engage their AdvancementsThe expansion of the online food delivery sector in the United States is mostly driven by technological developments. Customers may place orders with ease thanks to the growth of mobile apps and smooth online platforms, which provide real-time order monitoring, simple payment options, and AI-powered personalized recommendations. By cutting down on wait times and increasing customer satisfaction, GPS and route optimization technology increase delivery efficiency. The ordering process is further streamlined by integration with smart devices, such as voice assistants (like Alexa and Google Assistant). For instance, Uber Eats began deploying food delivery robots in a number of US locations in May systems can forecast demand, offer targeted discounts, and optimize menu offerings with the use of advanced data analytics. Additionally, artificial intelligence improves operational efficiency and helps with customer care through in the Online Food Delivery Market Intense CompetitionOne major obstacle in the US internet food delivery sector is fierce competition. Due to the dominance of some platforms, such as Uber Eats, DoorDash, Grubhub, and Postmates, it is challenging for new competitors to increase their market share. In order to draw clients, these well-known companies frequently use aggressive marketing strategies, providing loyalty plans, discounts, and alliances with well-known eateries. Due to the intense competition, platforms' and restaurants' profit margins are under strain as the emphasis moves from long-term sustainability to client acquisition. Differentiation and innovation are therefore essential for surviving in the competitive relianceOne of the biggest issues facing the online food delivery industry is third-party dependence. Restaurants depend on platforms for customer access and delivery services, but this creates a lack of control over the customer experience. Customer happiness may be impacted by order errors, delays, and uneven service quality. Furthermore, these platforms' exorbitant commission fees lower restaurant profit margins. Restaurants run the risk of being unduly dependent on outside parties as the market gets more competitive, which will hinder their capacity to interact directly with consumers and keep control over the quality of their brand and services. Company Analysis: Business Overview, Key Persons, Recent Development & Strategies, Sales Analysis Grubhub Doordash Uber Eats Postmates Dominos Pizza Inc. Kroger Co. Blue Apron Holdings HelloFresh Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $31.11 Billion Forecasted Market Value (USD) by 2033 $72.94 Billion Compound Annual Growth Rate 9.9% Regions Covered United States Key Topics Covered: 1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenge5. United States Online Food Delivery Market6. Market Share Analysis6.1 By Business Model6.2 By Platform Type6.3 By Payment Method6.4 By Cities7. Business Model7.1 Platform to customer delivery7.2 Restaurant to customer delivery8. Platform Type8.1 Websites8.2 Applications9. Payment Method9.1 Cash on delivery9.2 Online10. Cities10.1 Seattle10.2 Pittsburgh10.3 San Francisco10.4 Austin10.5 San Jose10.6 San Antonio10.7 Virginia Beach10.8 Miami10.9 San Diego10.10 Los Angeles10.11 Portland10.12 Atlanta10.13 Orlando10.14 Washington, DC10.15 Jacksonville10.16 Riverside10.17 Houston10.18 Sacramento10.19 Denver10.20 New York10.21 Tampa10.22 Tucson10.23 Dallas10.24 Salt Lake City10.25 Phoenix10.26 Others11. Porter's Five Forces Analysis11.1 Bargaining Power of Buyers11.2 Bargaining Power of Suppliers11.3 Degree of Rivalry11.4 Threat of New Entrants11.5 Threat of Substitutes12. SWOT Analysis12.1 Strength12.2 Weakness12.3 Opportunity12.4 Threat13. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Online Food Delivery Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-05-2025
- Health
- Yahoo
Osteoporosis Drugs Market Forecast Report and Company Analysis 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann-La Roche, GSK, Merck, Novartis, Pfizer, Teva, UCB
The aging population, growing awareness of bone health, the increasing frequency of fractures linked to osteoporosis, improvements in medication formulations, and the creation of more potent preventative and management therapies are the main factors propelling the growth of the osteoporosis medicine market. Global Osteoporosis Drugs Market Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Osteoporosis Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to Drugs Market is expected to reach US$ 26.70 billion by 2033 from US$ 18.18 billion in 2024, with a CAGR of 4.36% from 2025 to 2033 The aging population, growing awareness of bone health, the increasing frequency of fractures linked to osteoporosis, improvements in medication formulations, and the creation of more potent preventative and management therapies are the main factors propelling the growth of the osteoporosis medicine market. The need for efficient treatment options is anticipated to be fueled by the increasing incidence of osteoporosis, the aging population, and fragility fractures. The market for osteoporosis medications is expected to grow rapidly as a result of these demographic and health trends. For example, osteoporosis is becoming more common, with a 15.9% incidence in people 50 and older and a notable gender gap, according to a paper published in the Archives of Osteoporosis Journal in April 2024. Only 30% of people with osteoporosis receive the appropriate medication, and many fractures caused by the disease go undetected. This treatment gap is particularly noticeable in men. The need for osteoporosis medications is directly fueled by the growing need for diagnosis and treatment, which propels market osteoporosis development is linked to spinal cord injury. For example, July 2024 research in the BMC Medicine Journal states that more mobility issues and a higher risk of bone-related consequences result from the growing prevalence of spinal cord injuries, which have an overall incidence rate of 23.77 per million people. Effective treatment approaches are increasingly needed because people with spinal cord injuries are more likely to develop osteoporosis as a result of prolonged immobility. The market for osteoporosis medications is expanding as a result of the rising need for osteoporosis management during the projected period, the market expansion is anticipated to be bolstered by the increasing launches and approvals by industry participants. For example, a generic version of Forteo was approved for the U.S. market in November 2023 by Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. Injections of teriparatide are recommended for the treatment of osteoporosis in certain men and Drivers for the Osteoporosis Drugs Market Rising Prevalence of Osteoporotic FracturesThe need for osteoporosis medications is being driven mostly by the increasing incidence of osteoporotic fractures, especially in high-risk groups including postmenopausal women, the elderly, and people with underlying medical disorders. Osteoporotic fractures, which frequently result from weakening bones, can cause serious health issues like permanent impairment and immobility. As a result, preventive care and drugs that strengthen bones and halt bone loss are receiving more attention. Osteoporosis-related fractures are increasing in frequency as the world's population ages, which is driving patients and medical professionals to look for efficient pharmacological remedies. The market expansion for osteoporosis medications is further fueled by the rising frequency of fractures, which emphasizes the pressing need for improved in Drug DevelopmentDrug research advances for osteoporosis have produced more practical and efficient therapies, greatly enhancing patient outcomes. Recent developments provide alternatives to conventional medications that mainly target stopping bone resorption, such as bone-forming medicines and biologics that encourage bone regeneration. Furthermore, these more recent treatments frequently call for less frequent dosage, which improves patient compliance with treatment Initiatives and Healthcare AccessThe market for osteoporosis medications is expanding due in large part to government initiatives and better access to healthcare, particularly in emerging economies. Numerous governments are putting policies in place to raise awareness of bone health because they see osteoporosis as a serious health concern. These programs frequently involve increased availability of osteoporosis testing, preventative education, and treatment subsidies. Public health initiatives are also raising awareness of the significance of early disease detection and treatment. To guarantee that more people, especially in underprivileged areas, have access to essential treatments, governments are also investing in healthcare infrastructure. More people are being diagnosed and treated for osteoporosis as access to healthcare improves, which increases demand for osteoporosis medications and propels market in the Osteoporosis Drugs Market High Treatment CostsIn the market for osteoporosis medications, high treatment costs pose a serious problem, especially for more recent biologics and bone-forming medicines. Despite their effectiveness, many patients find these cutting-edge treatments to be financially stressful due to their high cost and continuous administration requirements. The cost of these drugs can be exorbitant in low- and middle-income nations with tight healthcare budgets, making them unavailable to people who need them the most. Because of this cost barrier, underprivileged communities experience greater rates of fractures and osteoporosis consequences due to unequal access to life-altering medicines. Furthermore, a lot of patients might not be able to pay for long-term treatment plans, which would compromise the medications' efficacy and hinder the best possible management of bone health. To address these issues, financial aid programs and reasonably priced medication solutions are Options for Certain Patient PopulationsA major obstacle in the market for osteoporosis medications is the lack of therapeutic choices for specific patient groups, such as those with severe osteoporosis or those who do not react to traditional medicines. Numerous current medications, such as hormone replacement therapy and bisphosphonates, work well for mild to moderate instances but might not be appropriate for more severe ones. There are frequently few options available to patients with severe osteoporosis or those who suffer side effects from conventional treatments. As a result, there is a significant unmet market need for alternative or more individualized medicines that can meet the needs of these particular patients. This gap could be filled by research into targeted medicines like gene therapies and biologics, which would provide these underprivileged people with more individualized and efficient treatment Analysis: Overview, Key Persons, Recent Development & Strategies, Product Portfolio, Financial Insights Amgen Inc. Eli Lilly and Company F. Hoffmann-La Roche AG GlaxoSmithKline Plc Merck & Co. Inc. Novartis AG Pfizer Inc. Teva Pharmaceutical Industries Ltd. UCB S.A. Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $18.18 Billion Forecasted Market Value (USD) by 2033 $26.7 Billion Compound Annual Growth Rate 4.3% Regions Covered Global Key Topics Covered: 1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Global Osteoporosis Drugs Market6. Market Share6.1 Market Breakup by Product Type6.2 Market Breakup by Route of Administration6.3 Country7. Product Type7.1 Bisphosphonates7.1.1 Market Trends7.1.2 Market Forecast7.2 Calcitonin7.2.1 Market Trends7.2.2 Market Forecast7.3 Rank Ligand Inhibitor7.3.1 Market Trends7.3.2 Market Forecast7.4 Parathyroid Hormone Therapy (PTH)7.4.1 Market Trends7.4.2 Market Forecast7.5 Selective Estrogen Receptor Modulators (SERMs)7.5.1 Market Trends7.5.2 Market Forecast7.6 Sclerostin Inhibitor7.6.1 Market Trends7.6.2 Market Forecast7.7 Others7.7.1 Market Trends7.7.2 Market Forecast8. Route of Administration8.1 Oral8.1.1 Market Trends8.1.2 Market Forecast8.2 Injectable8.2.1 Market Trends8.2.2 Market Forecast8.3 Others8.3.1 Market Trends8.3.2 Market Forecast9. Country9.1 North America9.1.1 United States9.1.2 Canada9.2 Europe9.2.1 France9.2.2 Germany9.2.3 Italy9.2.4 Spain9.2.5 United Kingdom9.2.6 Belgium9.2.7 Netherlands9.2.8 Turkey9.3 Asia Pacific9.3.1 China9.3.2 Japan9.3.3 India9.3.4 Australia9.3.5 South Korea9.3.6 Thailand9.3.7 Malaysia9.3.8 Indonesia9.3.9 New Zealand9.4 Latin America9.4.1 Brazil9.4.2 Mexico9.4.3 Argentina9.5 Middle East & Africa9.5.1 South Africa9.5.2 Saudi Arabia9.5.3 UAE10. Porter's Five Analysis10.1 Bargaining Power of Buyers10.2 Bargaining Power of Suppliers10.3 Degree of Rivalry10.4 Threat of New Entrants10.5 Threat of Substitutes11. SWOT Analysis11.1 Strength11.2 Weakness11.3 Opportunity11.4 Threat12. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Global Osteoporosis Drugs Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
15-05-2025
- Health
- Yahoo
Osteoporosis Drugs Market Forecast Report and Company Analysis 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann-La Roche, GSK, Merck, Novartis, Pfizer, Teva, UCB
The aging population, growing awareness of bone health, the increasing frequency of fractures linked to osteoporosis, improvements in medication formulations, and the creation of more potent preventative and management therapies are the main factors propelling the growth of the osteoporosis medicine market. Global Osteoporosis Drugs Market Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Osteoporosis Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to Drugs Market is expected to reach US$ 26.70 billion by 2033 from US$ 18.18 billion in 2024, with a CAGR of 4.36% from 2025 to 2033 The aging population, growing awareness of bone health, the increasing frequency of fractures linked to osteoporosis, improvements in medication formulations, and the creation of more potent preventative and management therapies are the main factors propelling the growth of the osteoporosis medicine market. The need for efficient treatment options is anticipated to be fueled by the increasing incidence of osteoporosis, the aging population, and fragility fractures. The market for osteoporosis medications is expected to grow rapidly as a result of these demographic and health trends. For example, osteoporosis is becoming more common, with a 15.9% incidence in people 50 and older and a notable gender gap, according to a paper published in the Archives of Osteoporosis Journal in April 2024. Only 30% of people with osteoporosis receive the appropriate medication, and many fractures caused by the disease go undetected. This treatment gap is particularly noticeable in men. The need for osteoporosis medications is directly fueled by the growing need for diagnosis and treatment, which propels market osteoporosis development is linked to spinal cord injury. For example, July 2024 research in the BMC Medicine Journal states that more mobility issues and a higher risk of bone-related consequences result from the growing prevalence of spinal cord injuries, which have an overall incidence rate of 23.77 per million people. Effective treatment approaches are increasingly needed because people with spinal cord injuries are more likely to develop osteoporosis as a result of prolonged immobility. The market for osteoporosis medications is expanding as a result of the rising need for osteoporosis management during the projected period, the market expansion is anticipated to be bolstered by the increasing launches and approvals by industry participants. For example, a generic version of Forteo was approved for the U.S. market in November 2023 by Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. Injections of teriparatide are recommended for the treatment of osteoporosis in certain men and Drivers for the Osteoporosis Drugs Market Rising Prevalence of Osteoporotic FracturesThe need for osteoporosis medications is being driven mostly by the increasing incidence of osteoporotic fractures, especially in high-risk groups including postmenopausal women, the elderly, and people with underlying medical disorders. Osteoporotic fractures, which frequently result from weakening bones, can cause serious health issues like permanent impairment and immobility. As a result, preventive care and drugs that strengthen bones and halt bone loss are receiving more attention. Osteoporosis-related fractures are increasing in frequency as the world's population ages, which is driving patients and medical professionals to look for efficient pharmacological remedies. The market expansion for osteoporosis medications is further fueled by the rising frequency of fractures, which emphasizes the pressing need for improved in Drug DevelopmentDrug research advances for osteoporosis have produced more practical and efficient therapies, greatly enhancing patient outcomes. Recent developments provide alternatives to conventional medications that mainly target stopping bone resorption, such as bone-forming medicines and biologics that encourage bone regeneration. Furthermore, these more recent treatments frequently call for less frequent dosage, which improves patient compliance with treatment Initiatives and Healthcare AccessThe market for osteoporosis medications is expanding due in large part to government initiatives and better access to healthcare, particularly in emerging economies. Numerous governments are putting policies in place to raise awareness of bone health because they see osteoporosis as a serious health concern. These programs frequently involve increased availability of osteoporosis testing, preventative education, and treatment subsidies. Public health initiatives are also raising awareness of the significance of early disease detection and treatment. To guarantee that more people, especially in underprivileged areas, have access to essential treatments, governments are also investing in healthcare infrastructure. More people are being diagnosed and treated for osteoporosis as access to healthcare improves, which increases demand for osteoporosis medications and propels market in the Osteoporosis Drugs Market High Treatment CostsIn the market for osteoporosis medications, high treatment costs pose a serious problem, especially for more recent biologics and bone-forming medicines. Despite their effectiveness, many patients find these cutting-edge treatments to be financially stressful due to their high cost and continuous administration requirements. The cost of these drugs can be exorbitant in low- and middle-income nations with tight healthcare budgets, making them unavailable to people who need them the most. Because of this cost barrier, underprivileged communities experience greater rates of fractures and osteoporosis consequences due to unequal access to life-altering medicines. Furthermore, a lot of patients might not be able to pay for long-term treatment plans, which would compromise the medications' efficacy and hinder the best possible management of bone health. To address these issues, financial aid programs and reasonably priced medication solutions are Options for Certain Patient PopulationsA major obstacle in the market for osteoporosis medications is the lack of therapeutic choices for specific patient groups, such as those with severe osteoporosis or those who do not react to traditional medicines. Numerous current medications, such as hormone replacement therapy and bisphosphonates, work well for mild to moderate instances but might not be appropriate for more severe ones. There are frequently few options available to patients with severe osteoporosis or those who suffer side effects from conventional treatments. As a result, there is a significant unmet market need for alternative or more individualized medicines that can meet the needs of these particular patients. This gap could be filled by research into targeted medicines like gene therapies and biologics, which would provide these underprivileged people with more individualized and efficient treatment Analysis: Overview, Key Persons, Recent Development & Strategies, Product Portfolio, Financial Insights Amgen Inc. Eli Lilly and Company F. Hoffmann-La Roche AG GlaxoSmithKline Plc Merck & Co. Inc. Novartis AG Pfizer Inc. Teva Pharmaceutical Industries Ltd. UCB S.A. Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $18.18 Billion Forecasted Market Value (USD) by 2033 $26.7 Billion Compound Annual Growth Rate 4.3% Regions Covered Global Key Topics Covered: 1. Introduction2. Research Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Global Osteoporosis Drugs Market6. Market Share6.1 Market Breakup by Product Type6.2 Market Breakup by Route of Administration6.3 Country7. Product Type7.1 Bisphosphonates7.1.1 Market Trends7.1.2 Market Forecast7.2 Calcitonin7.2.1 Market Trends7.2.2 Market Forecast7.3 Rank Ligand Inhibitor7.3.1 Market Trends7.3.2 Market Forecast7.4 Parathyroid Hormone Therapy (PTH)7.4.1 Market Trends7.4.2 Market Forecast7.5 Selective Estrogen Receptor Modulators (SERMs)7.5.1 Market Trends7.5.2 Market Forecast7.6 Sclerostin Inhibitor7.6.1 Market Trends7.6.2 Market Forecast7.7 Others7.7.1 Market Trends7.7.2 Market Forecast8. Route of Administration8.1 Oral8.1.1 Market Trends8.1.2 Market Forecast8.2 Injectable8.2.1 Market Trends8.2.2 Market Forecast8.3 Others8.3.1 Market Trends8.3.2 Market Forecast9. Country9.1 North America9.1.1 United States9.1.2 Canada9.2 Europe9.2.1 France9.2.2 Germany9.2.3 Italy9.2.4 Spain9.2.5 United Kingdom9.2.6 Belgium9.2.7 Netherlands9.2.8 Turkey9.3 Asia Pacific9.3.1 China9.3.2 Japan9.3.3 India9.3.4 Australia9.3.5 South Korea9.3.6 Thailand9.3.7 Malaysia9.3.8 Indonesia9.3.9 New Zealand9.4 Latin America9.4.1 Brazil9.4.2 Mexico9.4.3 Argentina9.5 Middle East & Africa9.5.1 South Africa9.5.2 Saudi Arabia9.5.3 UAE10. Porter's Five Analysis10.1 Bargaining Power of Buyers10.2 Bargaining Power of Suppliers10.3 Degree of Rivalry10.4 Threat of New Entrants10.5 Threat of Substitutes11. SWOT Analysis11.1 Strength11.2 Weakness11.3 Opportunity11.4 Threat12. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Global Osteoporosis Drugs Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
